Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
23 hedge funds and large institutions have $3.98M invested in Sophiris Bio, Inc. in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
15% more funds holding
Funds holding: 20 → 23 (+3)
32% less capital invested
Capital invested by funds: $5.82M → $3.98M (-$1.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$52.5K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$38.5K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$28.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.3K |
| 5 |
AIG
American International Group
New York
|
+$16.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$800K |
| 2 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
-$151K |
| 3 |
Morgan Stanley
New York
|
-$33.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$23K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Two Sigma Advisers
New York
| – | -$22K | -12,395 | Closed |
|
|
RCM
27
Rotella Capital Management
Bellevue,
Washington
| – | -$20K | -11,510 | Closed |
|
SPHS Hedge Fund Activity: Q1 2016 in Review
23 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q1 2016, worth a combined $3.98M — down 32% from $5.82M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SPHS positions and 4 closed out — a net gain of 3 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $52.5K. The largest seller was Boxer Capital, cutting an estimated $800K.
- 23 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q1 2016, up from 20 in Q4 2015.
- Funds reported $3.98M of Sophiris Bio, Inc. stock for Q1 2016, down 32% quarter-over-quarter.
- 7 funds opened new Sophiris Bio, Inc. positions in Q1 2016 and 4 closed out, a net change of +3 holders.
- The largest Sophiris Bio, Inc. buyer in Q1 2016 was Citadel Advisors, an estimated $52.5K added.
- The largest Sophiris Bio, Inc. seller in Q1 2016 was Boxer Capital, an estimated $800K sold.
Based on aggregated 13F filings for Q1 2016.